» Articles » PMID: 8352280

Functional Studies of a Germ-line Polymorphism at Codon 47 Within the P53 Gene

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1993 Sep 1
PMID 8352280
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

A rare germ-line polymorphism in codon 47 of the p53 gene replaces the wild-type proline (CCG) with a serine (TCG). Restriction analysis of 101 human samples revealed the frequency of the rare allele to be 0% (n = 69) in Caucasians and 4.7% (3/64, n = 32) among African-Americans. To investigate the consequence of this amino acid substitution, a cDNA construct (p53 mut47ser) containing the mutation was introduced into a lung adenocarcinoma cell line (Calu-6) that does not express p53. A growth suppression similar to that obtained after introduction of a wild-type p53 cDNA construct was observed, in contrast to the result obtained by introduction of p53 mut143ala. Furthermore, expression of neither p53 mut47ser nor wild-type p53 was tolerated by growing cells. In transient expression assays, both mut47ser and wild-type p53 activated the expression of a reporter gene linked to a p53 binding sequence (PG13-CAT) and inhibited the expression of the luciferase gene under the control of the Rous sarcoma virus promoter (RSVluc). In the same assay, mut143ala did not activate the expression of PG13-CAT and produced only a slight inhibitory effect on RSVluc. These findings indicate that the p53 variant with a serine at codon 47 should be considered as a rare germ-line polymorphism that does not alter the growth-suppression activity of p53.

Citing Articles

Emerging insights into ethnic-specific TP53 germline variants.

Fischer N, Ma Y, Gariepy J J Natl Cancer Inst. 2023; 115(10):1145-1156.

PMID: 37352403 PMC: 10560603. DOI: 10.1093/jnci/djad106.


Neither the African-Centric S47 Nor P72 Variant of TP53 Is Associated With Reduced Risk of Febrile Malaria in a Malian Cohort Study.

Bhardwaj J, Upadhye A, Gaskin E, Doumbo S, Kayentao K, Ongoiba A J Infect Dis. 2023; 228(2):202-211.

PMID: 36961831 PMC: 10345479. DOI: 10.1093/infdis/jiad066.


Identification and functional characterization of new missense SNPs in the coding region of the TP53 gene.

Doffe F, Carbonnier V, Tissier M, Leroy B, Martins I, Mattsson J Cell Death Differ. 2020; 28(5):1477-1492.

PMID: 33257846 PMC: 8166836. DOI: 10.1038/s41418-020-00672-0.


TP53 genetic polymorphisms and susceptibility to cervical cancer in Bangladeshi women: a case-control study.

Apu M, Rashed A, Bashar T, Rahman M, Mostaid M Mol Biol Rep. 2020; 47(6):4357-4364.

PMID: 32424519 DOI: 10.1007/s11033-020-05523-2.


How the Other Half Lives: What p53 Does When It Is Not Being a Transcription Factor.

Ho T, Tan B, Lane D Int J Mol Sci. 2019; 21(1).

PMID: 31861395 PMC: 6982169. DOI: 10.3390/ijms21010013.


References
1.
Frebourg T, Kassel J, Lam K, Gryka M, Barbier N, Andersen T . Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Proc Natl Acad Sci U S A. 1992; 89(14):6413-7. PMC: 49511. DOI: 10.1073/pnas.89.14.6413. View

2.
Weston A, Perrin L, Forrester K, Hoover R, Trump B, Harris C . Allelic frequency of a p53 polymorphism in human lung cancer. Cancer Epidemiol Biomarkers Prev. 1992; 1(6):481-3. View

3.
Agoff S, Hou J, Linzer D, Wu B . Regulation of the human hsp70 promoter by p53. Science. 1993; 259(5091):84-7. DOI: 10.1126/science.8418500. View

4.
Eliyahu D, Raz A, Gruss P, Givol D, Oren M . Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature. 1984; 312(5995):646-9. DOI: 10.1038/312646a0. View

5.
Parada L, Land H, Weinberg R, Wolf D, Rotter V . Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature. 1984; 312(5995):649-51. DOI: 10.1038/312649a0. View